| No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
| 1 | general cells |
IFO50005 |
J-111 |
human |
blood |
HeLa markers* |
|
| 2 | general cells |
IFO50006 |
M1 |
mouse |
bone marrow |
Spontaneously occurred mouse myeloid leukemia, differentiate into macrophage/granulocyte. |
|
| 3 | general cells |
IFO50248 |
IT-79MTNC3 |
mouse |
thymus |
thymic nurse cell, (BALB/c mouse) |
|
| 4 | general cells |
IFO50357 |
KNS-60 |
human |
brain |
glioma, GFAP, S-100 and NSE-negative |
|
| 5 | general cells |
IFO50424 |
AP-16 |
mouse |
brain, astrocyte-progenitor cell |
Astrocyte differentiation is induced by TGF-beta, LIF, CNTF and serum The deprivation of EGF induces death of AP-16 cells by apoptosis. |
|
| 6 | general cells |
IFO50488 |
OUMS-27 |
human |
bone, left proimal humerus |
chondrosarcoma, type 1 ,2 and 3 collagens; type 9 and 11 collagen mRNA; proteoglycan-producing |
|
| 7 | general cells |
IFO50489 |
GB-1 |
human |
brain |
glioma, GFAP, vimentin and fibronectin-positive |
|
| 8 | general cells |
IFO50493 |
YH-13 |
human |
brain |
glioblastoma, GFAP and S-100-positive, ACNU(a cancer chemotherapy drug)-resistant |
|
| 9 | general cells |
IFO50513 |
MTA |
human |
peripheral blasts |
leukemia, NK-like T cell line |
|
| 10 | general cells |
JCRB0075 |
SF-TY |
human |
skin |
normal fibroblast |
|
| 11 | general cells |
JCRB0125 |
L alpha |
mouse |
loose connective tissue |
L cell line introduced with poliovirus receptor protein alpha gene, thymidine kinase defective |
|
| 12 | general cells |
JCRB0134 |
MCF-7 |
human |
pleural effusion |
Human metastatic mammary carcinoma cell line. |
|
| 13 | general cells |
JCRB0145 |
MEB 5 |
mouse |
forebrain |
Multipotent CNS stem cell line of mouse. Cells differentiate into neuron, astrocytes and oligodendrocytes. |
|
| 14 | general cells |
JCRB0156 |
KHYG-1 |
human |
peripheral blood |
Human natural killer cell line with a p53 point mutation as a model for p53-associated leukemogenesis and a model for differentiation of NK/T cells. |
|
| 15 | general cells |
JCRB0167 |
RCN-9 |
rat |
colon |
DMH induced colonic cancer, (F344/DuCrj rat) |
|
| 16 | general cells |
JCRB0186 |
OV3121ras4 |
mouse |
ovary |
Mouse ovarian granulosa cell tumor line with v-Ha-ras gene. |
|
| 17 | general cells |
JCRB0713 |
HeLa S3 (sc) |
human |
cervix |
HeLa derivative, can grow in suspension culture |
|
| 18 | general cells |
JCRB1010 |
KMRC-1 |
human |
kidney |
Human tumor cell line from kidney. Clear cell renal carcinoma cell line. |
|
| 19 | general cells |
JCRB1027 |
SAT |
human |
oral cavity |
Human squamous cell carcinoma with non-metastatic cell line derived from oral cavity. |
|
| 20 | general cells |
JCRB1048 |
OVTOKO |
human |
spleen metastatic focus |
Human cell line derived from ovarian tumour. |
|
| 21 | general cells |
JCRB1053 |
STC 1 |
human |
lung |
Human small cell lung carcinoma. |
|
| 22 | general cells |
JCRB1067 |
CPT-K5 |
human |
|
Mutant cell line derived from human ALL cell line, RPMI8402. |
|
| 23 | general cells |
JCRB1073 |
ASH-3 |
human |
cervical tissue |
Tumor cell line with multidrug registance obtained from rapidly growing cervical tumor(neck) diagnosed as an anaplastic thyroid carcinoma. |
|
| 24 | general cells |
JCRB1074 |
FU97 |
human |
stomach |
Human stomach cancer cell line with AFP production. |
|
| 25 | general cells |
JCRB1146 |
RSMG-1 |
rat |
selection from whole body culture |
Stem cell like cell line from female rat submandibular gland. |
|
| 26 | general cells |
JCRB1147 |
UE7T-9 |
human |
bone marrow |
Human bone marrow-derived mesenchymal stem cells. |
|
| 27 | general cells |
JCRB1153 |
HCA-1 |
human |
lymph node metastasis |
Human endocervical adenocarcinoma cell line. |
|
| 28 | general cells |
JCRB1178 |
KUM5 |
mouse |
bone marrow |
Osteoblastic cell line of mouse C3H. |
|
| 29 | general cells |
JCRB1187 |
KMS-26 |
human |
pleural effusion |
human myeloma cell line. |
|
| 30 | general cells |
JCRB1222.07 |
HGH1.8.1 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). |
|
| 31 | general cells |
JCRB1304 |
MT-45-5-3 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against metallothionein. |
|
| 32 | general cells |
JCRB1316.1 |
OHP57.G6.1 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against 17alpha-hydroxyprogesterone. |
|
| 33 | genetically-modified cells |
JCRB1318 |
HeLa9903 |
human |
|
hERalpha-HeLa-9903, transfected with estrogen receptor-alpha - reporter gene construct. |
|
| 34 | general cells |
JCRB1319 |
PL-21 |
human |
white blood |
Human myeloid cell line derived from an acute promyelocytic leukemia. |
|
| 35 | genetically-modified cells |
JCRB1328 |
AR-EcoScreen |
hamster, Chinese |
Ovary |
AR-EcoScreen is for evaluation of a rapid in vitro androgen receptor tarnscriptional activation assay. |
|
| 36 | general cells |
JCRB1332 |
NALL-1 |
human |
peripheral blood |
Human 'null' cell from ALL cell line. |
|
| 37 | general cells |
JCRB1342.10 |
MOR33.2.9 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against morphine. |
|
| 38 | general cells |
JCRB1346 |
FLAM-76 |
human |
|
Interleukin-6-dependent human myeloma cell line from an agressive nonsecretory plasma cell leukemia. |
|
| 39 | general cells |
JCRB1347 |
KML-1 |
human |
pleural effusion |
Human B-cell lymphoma cell line. |
|
| 40 | general cells |
JCRB1348 |
3LL |
mouse |
Lung |
Lewis lung carcinoma cell line. |
|
| 41 | general cells |
JCRB1357 |
1-1src |
mouse |
embryo, whole |
The src-transformed BALB/c 3T3 A31-1-1 variant cell lines were strongly tumorinenic and metastatic.(Strain problem was found. Refer Important Notice at cell detail page.) |
|
| 42 | general cells |
JCRB1380 |
HBs320 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against HBs antigen. |
|
| 43 | general cells |
JCRB1385 |
CAS-9 |
mouse x rat |
|
Hybridoma cell line producing antibody against mouse CD49d (VLA-4 a chain). Binding inhibition VLA-4/Fibronectin. |
|
| 44 | genetically-modified cells |
JCRB1459 |
HUEhT-2 |
human |
human umbilical vein |
Immortalized human umbilical vein endothelial cell line established (HUVEC) by electroporation of pIRES-hTERT-hygr. |
|
| 45 | genetically-modified cells |
JCRB1514 |
POLK KO homo MSH- |
human |
peripheral blood |
Human cell line derived from B cell leukemia. (MSH-, POLK KO/KO, TK+/+) |
|
| 46 | genetically-modified cells |
JCRB1523 |
POLK CD MSH- |
human |
peripheral blood |
Human cell line derived from B cell leukemia. (MSH-, POLK catalytically dead, TK+/+) |
|
| 47 | genetically-modified cells |
JCRB1534 |
IKK-i-DEF |
mouse |
embryo |
Mouse embryonic fibroblasts prepared from IkB kinase (IKK-i) deficient mice. |
|
| 48 | general cells |
JCRB1750 |
XYFMGC07K |
human |
blood |
EBV transformed B-cell lymphoblastoid cell line from human XY female. |
|
| 49 | general cells |
JCRB1782 |
BALM-7 |
human |
bone marrow |
B cell leukemia cell line |
|
| 50 | general cells |
JCRB1790 |
BALM-9N |
human |
peripheral blood |
B cell leukemia cell line |
|
| 51 | general cells |
JCRB1801 |
BALM-25 |
human |
bone marrow |
B cell leukemia cell line, ALL-L3 cell line |
|
| 52 | general cells |
JCRB1817 |
BALM-21 |
human |
bone marrow |
B cell leukemia cell line, ALL-L2 cell line, hypercalcemia |
|
| 53 | general cells |
JCRB1843 |
BALM-24 |
human |
peripheral blood |
B cell leukemia cell line, ALL-L3 cell line, t(8;14)(q24.1;q32) |
|
| 54 | genetically-modified cells |
JCRB1845 |
HeLa-ACE2 |
human |
cervix |
HeLa cells expressing angiotensin-converting enzyme-related carboxypeptidase (ACE2). Recommended use:Comparative control with HeLa-ACE2-TMPRSS2 cells |
|
| 55 | general cells |
JCRB1870 |
OCUT-2 |
human |
Thoracic fluid |
human anaplastic thyroid cancer cell line |
|
| 56 | genetically-modified cells |
JCRB1970 |
MDCK-QKO |
dog |
kidney |
Epidermal growth factor (EGF), heparin-binding EGF (HBEGF), transforming growth factor alpha (TGFalpha), and epiregulin (EREG)-quadruple deficient MDCK cell line. |
|
| 57 | general cells |
JCRB1977 |
HCF-MLp-N |
human |
Metastasis in cerebrospinal fluid |
human B-cell line derived from non-Hodgkin's lymphoma, Primary Central Nervous System Lymphoma, PCNSL |
|
| 58 | general cells |
JCRB2208 |
A9(Neo8) |
human chromosome-introduced |
skin |
contains human chromosome # 8 (MTA with Tottori Univ. is required.) |
|
| 59 | general cells |
JCRB2215 |
A9(Neo15) |
human chromosome-introduced |
skin |
contains human chromosome #15 (MTA with Tottori Univ. is required.)
|
|
| 60 | general cells |
JCRB4091 |
NCC-GCTB10-C1 |
human |
Left proximal tibia |
Giant cell tumor cell line |
|
| 61 | general cells |
JCRB9003 |
NCTC Clone 929 |
mouse |
|
fibroblast, subclone of strain L, (C3H/An mouse) |
|
| 62 | general cells |
JCRB9033 |
STK1 |
mouse |
hybridoma |
anti-DNA polymerase alpha, IgG1 |
|
| 63 | general cells |
JCRB9039 |
Pt K1 |
marsupial (potoroo, rat kangar |
kidney |
kidney |
|
| 64 | general cells |
JCRB9083 |
LoVo |
human |
colon |
adenocarcinoma, carcinoembryonic antigen-producing |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.